Meet Our Keynote Speakers
Healthcare's Digital Evolution
It's easy to agree with the idea of holistic, coordinated and seamless care that makes life better for patients, providers and payers. But getting there is no easy task. As the International Healthcare Innovation professor at Harvard Medical School, John Halamka, MD is a visionary and renowned champion for connected care. As Chief Information Officer of Beth Israel Deaconess System and a leader in a major New England healthcare network, he is positioned to deploy his ideas. Come hear what's working, what's not, and how we can all move toward care models that improve health and drive value.
Better Health Needs Champions
Whether running all out to cross the finish-line first, performing death-defying snowboard moves on a mountainside, or driving hard down the soccer field, the women of this panel know what it takes to be a champion. They also know the challenges of facing chronic and complex medical conditions – but not letting their ailments slow down or define them. Led by moderator Phyllis Anderson, Express Scripts Chief Marketing Officer, these celebrated women will share their patient and athletic journeys.
Shannon Boxx
Three-Time Olympic Gold Medalist
Shannon Boxx, a retired midfielder of the American soccer team that three times scored Olympic gold and a FIFA Women's World Cup star, today supports the cause of curing Lupus and Sjogren's syndrome.
Read Full BioSpencer O'Brien
Five-Time Winter X Games Medalist
Spencer O'Brien, a professional snowboarder from the age of 16, and winner of five Winter X Games medals, was diagnosed with RA just months before competing in the 2014 Winter Olympics. She is active as a role model for Canadian youth.
Read Full BioJackie Joyner-Kersee
Three-Time Olympic Gold Medalist
Jackie Joyner-Kersee, one of the most decorated athletes of all time, dominated the track and field circuit over four Olympic games – all while learning to live with asthma.
Read Full BioAlso on the Mainstage
Phyllis Anderson
Senior Vice President & Chief Marketing Officer
Snezana Mahon, PharmD
VP & GM Product Management, Clinical Programs
Steve Miller, MD
Senior Vice President & Chief Medical Officer
Lynne Nowak, MD
Chief Physician Experience Officer
Dave Queller
Senior Vice President, Sales & Account Management
Tim Wentworth
Chief Executive Officer & President
Breakout Session Topics
To Care for the Rare: A New Solution for Rare Disease Cost and Care Management
Although rare diseases may seem uncommon, the class as a whole poses significant cost and care challenges. Providing coverage for even one member with a rare disease can cost $1 million or more – potentially devastating your plan spend. And for that one member, finding the right care is physically and mentally challenging. With 1 in 10 Americans living with a rare disease, are you prepared?
Also consider these companion breakouts:
- Stop, Collaborate and Listen: Working Together to Prevent Rare Disease Costs from Mounting
- Cracking the Code on Gene Therapies
Better Care or Lower Costs? Achieving Both with Value-Based Strategies
You hear a lot about value-based strategies in healthcare, but what does it mean for your plan and members? In this session, you'll see the impact that value-based strategies are having on the costliest, most complex conditions. Stop by to learn how clients like you are seeing substantial plan savings and how members are experiencing improved clinical outcomes.
Let's Get Right to the Point (Of Care!) Enabling Physicians, Improving Outcomes
When physicians have the right tools and information at the point of care, the best possible decisions are made for your members. Come learn how enabled physicians provide better quality of care at the lowest possible cost, not just for you, but everyone in the healthcare chain.
Stop, Collaborate and Listen: Working Together to Prevent Rare Disease Costs from Mounting
The top 10 most expensive drugs in the world treat rare and ultra-rare diseases, and although the number of patients who face these conditions may be low, the costs can be extremely high. That’s why we’ve developed new solutions to protect you and your members from unnecessary treatment, expenses and catastrophic claims. We’ll share the latest, alongside our newest, exclusive partners who’ll address a unique Second Opinion program. Don’t miss these companion breakouts: “Cracking the code on gene therapies” and “To care for the rare: A new solution for rare disease cost management”
Also consider these companion breakouts:
- To Care for the Rare: A New Solution for Rare Disease Cost and Care Management
- Cracking the Code on Gene Therapies
Cracking the Code on Gene Therapies
The advent of gene therapy holds incredible promise for patients, but payers like you must understand the implications of a rapidly growing and changing market. Join us as we demystify these revolutionary new drugs and discuss how we're laying the foundation for a future management strategy.
Also consider these companion breakouts:
- To Care for the Rare: A New Solution for Rare Disease Cost and Care Management
- Stop, Collaborate and Listen: Working Together to Prevent Rare Disease Costs from Mounting
Taking On Healthcare's Toughest Challenge... Human Behavior
Anyone who has ever made a New Year's Resolution knows that good intentions only get you so far. We know most healthcare decisions don't happen in a doctor's office. They happen at home, in the grocery aisle or at work, where they battle for our attention. Learn how technology, empathy, service and creativity work together to help members get better health, wherever they are.
Q&A: How the Quality and Accountability of Your Pharmacy Network Impact Your Plan
The quality care of our network and clinical solutions yields savings and drives member adherence, all while managing member transitions and concerns. Learn how designing the right network strategy can pair seamlessly with clinical solutions that lead to healthier outcomes.
Is Your Medicare Plan Stuck in Neutral? Strategies to Position for Competitive Growth
Whether it's adopting value-based networks or executing proven adherence solutions to reduce your Medicare plan costs, learn what it takes to profitably grow your Medicare lives and make sure you aren't left behind as the Medicare landscape continues to evolve.
Hope is not a strategy: Protecting your plan from the next storm
Populations shift overnight. You never know when a member will become diagnosed with a costly, complex chronic condition or whether that member will respond to therapy. Having the right tools in place now can contain these concerns when they happen. Learn how to protect your plan from the catastrophic and be prepared to manage costs when changes occur overnight.
The New Frontier: Transforming Drug Therapies from Treatments to Cures
The pharmaceutical industry is taking the next critical step in making, and keeping, people healthier. Join us as we explore exciting, new break-through drugs, how they'll change the industry and your members' health and what you need to know to prepare for them.
No More Sugar-Coating: An End-to-End Diabetes Management Approach
Diabetes is a complex chronic condition affecting over 30 million Americans. The barriers are endless for optimal disease management – from financial strains of diabetes when not managed properly, to countless disconnects between health plans, payers, physicians and pharmacies. But, what if there was a way to harness the power of all healthcare entities involved to provide a more effective experience in managing this prevalent disease?
The Patient Killer: What Are You Doing to Combat Opioid Abuse?
We all know by now that the opioid epidemic is the worst drug crisis in American history. However, what most people don't know is how the different healthcare entities are working together to put a stop to it. What does the next generation of opioid management look like and do you know how you specifically can help stop the opioid epidemic?
A View from the Hill: Understanding Healthcare Policy Today and Tomorrow
Five months from mid-term elections, what changes to pharmacy benefits have come to pass with the new administration? What additional changes can we expect at the Federal and State levels? And what actions can you take to help make the healthcare system better through your advocacy?